Gena Heidary, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oculomotor Muscles | 9 | 2022 | 371 | 2.650 |
Why?
|
Papilledema | 8 | 2023 | 118 | 2.390 |
Why?
|
Ophthalmology | 14 | 2023 | 508 | 2.360 |
Why?
|
Optic Nerve Glioma | 3 | 2024 | 32 | 2.260 |
Why?
|
Strabismus | 7 | 2022 | 287 | 2.250 |
Why?
|
Vision Disorders | 8 | 2023 | 1058 | 2.220 |
Why?
|
Optic Neuritis | 7 | 2022 | 166 | 2.170 |
Why?
|
Visual Acuity | 12 | 2022 | 2530 | 1.890 |
Why?
|
Optic Disk Drusen | 3 | 2023 | 35 | 1.760 |
Why?
|
Neurofibromatosis 1 | 4 | 2024 | 569 | 1.650 |
Why?
|
Pseudotumor Cerebri | 6 | 2023 | 100 | 1.620 |
Why?
|
Optic Disk | 5 | 2023 | 400 | 1.550 |
Why?
|
Esotropia | 4 | 2021 | 91 | 1.510 |
Why?
|
Ophthalmoplegia | 4 | 2021 | 166 | 1.260 |
Why?
|
Nystagmus, Pathologic | 5 | 2023 | 96 | 1.220 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2019 | 245 | 1.150 |
Why?
|
Amblyopia | 4 | 2023 | 143 | 1.120 |
Why?
|
Visual Pathways | 3 | 2021 | 565 | 1.060 |
Why?
|
Tomography, Optical Coherence | 11 | 2024 | 2657 | 1.000 |
Why?
|
Optic Nerve Diseases | 5 | 2023 | 327 | 0.950 |
Why?
|
Ophthalmologic Surgical Procedures | 6 | 2022 | 349 | 0.860 |
Why?
|
Spasms, Infantile | 2 | 2021 | 305 | 0.750 |
Why?
|
Intracranial Hypertension | 3 | 2018 | 186 | 0.730 |
Why?
|
Neuromyelitis Optica | 2 | 2022 | 252 | 0.710 |
Why?
|
Orbital Cellulitis | 1 | 2019 | 33 | 0.670 |
Why?
|
Brain Diseases | 2 | 2019 | 1563 | 0.660 |
Why?
|
Evoked Potentials, Visual | 1 | 2021 | 427 | 0.650 |
Why?
|
Vision, Ocular | 1 | 2021 | 464 | 0.620 |
Why?
|
Academies and Institutes | 6 | 2021 | 317 | 0.610 |
Why?
|
Child | 41 | 2024 | 77709 | 0.600 |
Why?
|
Choroid | 1 | 2019 | 322 | 0.590 |
Why?
|
Fibrosis | 3 | 2020 | 2029 | 0.580 |
Why?
|
Streptococcus pyogenes | 1 | 2019 | 289 | 0.580 |
Why?
|
Optic Atrophy | 2 | 2014 | 79 | 0.580 |
Why?
|
Infratentorial Neoplasms | 1 | 2017 | 94 | 0.570 |
Why?
|
Suture Techniques | 1 | 2021 | 798 | 0.560 |
Why?
|
Eye Infections, Bacterial | 1 | 2019 | 235 | 0.550 |
Why?
|
Optic Nerve Neoplasms | 1 | 2016 | 44 | 0.550 |
Why?
|
Tubulin | 1 | 2019 | 695 | 0.540 |
Why?
|
Technology Assessment, Biomedical | 4 | 2021 | 306 | 0.520 |
Why?
|
Forecasting | 2 | 2015 | 2951 | 0.520 |
Why?
|
Visual Fields | 3 | 2020 | 1047 | 0.510 |
Why?
|
Blindness | 1 | 2019 | 617 | 0.500 |
Why?
|
Streptococcal Infections | 1 | 2019 | 638 | 0.500 |
Why?
|
Nerve Fibers | 5 | 2024 | 687 | 0.480 |
Why?
|
Ependymoma | 1 | 2017 | 334 | 0.480 |
Why?
|
Peptide Termination Factors | 1 | 2014 | 55 | 0.470 |
Why?
|
Vision, Binocular | 5 | 2021 | 213 | 0.460 |
Why?
|
Blepharoptosis | 2 | 2021 | 143 | 0.460 |
Why?
|
Leigh Disease | 1 | 2014 | 75 | 0.450 |
Why?
|
Astrocytoma | 1 | 2017 | 790 | 0.430 |
Why?
|
Multiple Sclerosis | 4 | 2022 | 3079 | 0.420 |
Why?
|
Medulloblastoma | 1 | 2017 | 683 | 0.410 |
Why?
|
Retinal Ganglion Cells | 4 | 2024 | 770 | 0.400 |
Why?
|
Eye Diseases | 1 | 2017 | 669 | 0.400 |
Why?
|
Retinal Diseases | 1 | 2017 | 683 | 0.390 |
Why?
|
Myopia | 2 | 2022 | 254 | 0.390 |
Why?
|
Down Syndrome | 2 | 2016 | 880 | 0.380 |
Why?
|
Child, Preschool | 20 | 2022 | 41006 | 0.370 |
Why?
|
Duane Retraction Syndrome | 2 | 2021 | 60 | 0.370 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2421 | 0.360 |
Why?
|
Siblings | 1 | 2014 | 854 | 0.350 |
Why?
|
Abducens Nerve Diseases | 2 | 2020 | 43 | 0.340 |
Why?
|
Retina | 2 | 2021 | 2616 | 0.340 |
Why?
|
Neurodegenerative Diseases | 1 | 2017 | 1061 | 0.320 |
Why?
|
Humans | 60 | 2024 | 744343 | 0.270 |
Why?
|
Fellowships and Scholarships | 3 | 2023 | 1076 | 0.270 |
Why?
|
Fluorescein Angiography | 2 | 2020 | 940 | 0.260 |
Why?
|
Astigmatism | 1 | 2005 | 69 | 0.250 |
Why?
|
Retinopathy of Prematurity | 1 | 2009 | 421 | 0.240 |
Why?
|
Refraction, Ocular | 1 | 2005 | 182 | 0.240 |
Why?
|
Eye Movements | 3 | 2022 | 507 | 0.230 |
Why?
|
Retrospective Studies | 19 | 2023 | 77449 | 0.230 |
Why?
|
Anisometropia | 1 | 2022 | 13 | 0.220 |
Why?
|
Photorefractive Keratectomy | 1 | 2022 | 38 | 0.210 |
Why?
|
Adolescent | 17 | 2024 | 85781 | 0.210 |
Why?
|
Cataract Extraction | 2 | 2019 | 481 | 0.200 |
Why?
|
Orthoptics | 1 | 2021 | 10 | 0.200 |
Why?
|
Mobius Syndrome | 1 | 2021 | 40 | 0.200 |
Why?
|
Jaw Abnormalities | 1 | 2021 | 27 | 0.200 |
Why?
|
Optic Nerve | 2 | 2016 | 554 | 0.200 |
Why?
|
Accommodation, Ocular | 1 | 2021 | 48 | 0.200 |
Why?
|
Reflex, Abnormal | 1 | 2021 | 84 | 0.190 |
Why?
|
Genes, Insect | 1 | 2001 | 268 | 0.190 |
Why?
|
Visual Field Tests | 1 | 2023 | 383 | 0.190 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2020 | 48 | 0.190 |
Why?
|
Apraxias | 1 | 2021 | 64 | 0.190 |
Why?
|
Arthrogryposis | 1 | 2021 | 72 | 0.190 |
Why?
|
Dacryocystorhinostomy | 1 | 2020 | 72 | 0.180 |
Why?
|
Nasolacrimal Duct | 1 | 2020 | 74 | 0.180 |
Why?
|
Ocular Motility Disorders | 1 | 2021 | 135 | 0.180 |
Why?
|
Sulbactam | 1 | 2019 | 26 | 0.180 |
Why?
|
DNA | 1 | 2014 | 7301 | 0.180 |
Why?
|
Neuromuscular Agents | 1 | 2021 | 134 | 0.170 |
Why?
|
Delivery of Health Care | 1 | 2018 | 5319 | 0.170 |
Why?
|
Morbidity | 2 | 2023 | 1769 | 0.170 |
Why?
|
Ampicillin | 1 | 2019 | 139 | 0.170 |
Why?
|
Sutures | 1 | 2021 | 299 | 0.170 |
Why?
|
Aphakia, Postcataract | 1 | 2019 | 54 | 0.170 |
Why?
|
Eye Diseases, Hereditary | 1 | 2020 | 117 | 0.170 |
Why?
|
Cranial Fontanelles | 1 | 2018 | 11 | 0.170 |
Why?
|
Aquaporin 4 | 1 | 2020 | 153 | 0.170 |
Why?
|
Cerebrospinal Fluid Pressure | 1 | 2018 | 35 | 0.170 |
Why?
|
Postoperative Complications | 2 | 2019 | 15295 | 0.170 |
Why?
|
Receptors, Bombesin | 1 | 1998 | 27 | 0.160 |
Why?
|
Contracture | 1 | 2021 | 223 | 0.160 |
Why?
|
Mutation | 4 | 2021 | 29786 | 0.160 |
Why?
|
Botulinum Toxins, Type A | 1 | 2021 | 213 | 0.160 |
Why?
|
Male | 24 | 2024 | 350118 | 0.160 |
Why?
|
Ophthalmic Solutions | 1 | 2019 | 317 | 0.160 |
Why?
|
Muscular Atrophy | 1 | 2021 | 349 | 0.150 |
Why?
|
Contact Lenses | 1 | 2019 | 145 | 0.150 |
Why?
|
Eyeglasses | 1 | 2019 | 145 | 0.150 |
Why?
|
Lens Implantation, Intraocular | 1 | 2019 | 192 | 0.150 |
Why?
|
Algorithms | 1 | 2018 | 13881 | 0.150 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2021 | 372 | 0.150 |
Why?
|
Fundus Oculi | 2 | 2020 | 473 | 0.140 |
Why?
|
Female | 25 | 2024 | 380194 | 0.140 |
Why?
|
Magnetic Resonance Imaging | 9 | 2021 | 35421 | 0.140 |
Why?
|
Infant | 8 | 2019 | 35136 | 0.140 |
Why?
|
Rett Syndrome | 1 | 1998 | 165 | 0.140 |
Why?
|
Retinal Neurons | 1 | 2016 | 66 | 0.140 |
Why?
|
Neurofibroma, Plexiform | 1 | 2016 | 71 | 0.140 |
Why?
|
Vancomycin | 1 | 2019 | 501 | 0.130 |
Why?
|
Eyelid Neoplasms | 1 | 2016 | 94 | 0.130 |
Why?
|
Steroids | 1 | 2020 | 930 | 0.130 |
Why?
|
Leukemia | 1 | 2023 | 1511 | 0.130 |
Why?
|
Arnold-Chiari Malformation | 1 | 2016 | 154 | 0.130 |
Why?
|
Ultrasonography | 2 | 2019 | 5985 | 0.120 |
Why?
|
X Chromosome | 1 | 1998 | 814 | 0.120 |
Why?
|
Orbital Neoplasms | 1 | 2016 | 225 | 0.120 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2291 | 0.120 |
Why?
|
Drosophila | 1 | 2001 | 1491 | 0.120 |
Why?
|
World Health Organization | 1 | 2019 | 1318 | 0.110 |
Why?
|
Drug Therapy, Combination | 2 | 2023 | 6489 | 0.110 |
Why?
|
Perceptual Disorders | 1 | 2014 | 196 | 0.110 |
Why?
|
Drosophila Proteins | 1 | 2001 | 1703 | 0.100 |
Why?
|
Internship and Residency | 2 | 2022 | 5788 | 0.100 |
Why?
|
tau Proteins | 1 | 2001 | 1868 | 0.100 |
Why?
|
Autoantibodies | 1 | 2020 | 2035 | 0.100 |
Why?
|
Prospective Studies | 4 | 2024 | 53288 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2915 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1622 | 0.090 |
Why?
|
Craniosynostoses | 1 | 2014 | 401 | 0.090 |
Why?
|
Phenotype | 2 | 2021 | 16365 | 0.090 |
Why?
|
United States | 10 | 2023 | 69872 | 0.090 |
Why?
|
Adult | 11 | 2023 | 214055 | 0.090 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2014 | 957 | 0.080 |
Why?
|
Trochlear Nerve | 1 | 2008 | 25 | 0.080 |
Why?
|
Oculomotor Nerve | 1 | 2008 | 74 | 0.080 |
Why?
|
Longitudinal Studies | 1 | 2024 | 13989 | 0.080 |
Why?
|
Mitochondrial Proteins | 1 | 2014 | 996 | 0.080 |
Why?
|
Pediatrics | 1 | 2022 | 3475 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25043 | 0.070 |
Why?
|
Prevalence | 3 | 2016 | 15226 | 0.070 |
Why?
|
Maternal-Fetal Exchange | 1 | 2009 | 456 | 0.070 |
Why?
|
Cataract | 1 | 2012 | 834 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5853 | 0.070 |
Why?
|
Acute Disease | 1 | 2016 | 7149 | 0.070 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39050 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6895 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4186 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20129 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4445 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 4584 | 0.060 |
Why?
|
Erythropoietin | 1 | 2009 | 726 | 0.060 |
Why?
|
Carbidopa | 1 | 2023 | 31 | 0.060 |
Why?
|
Pandemics | 1 | 2023 | 8388 | 0.060 |
Why?
|
Sensory Deprivation | 1 | 2023 | 109 | 0.060 |
Why?
|
Levodopa | 1 | 2023 | 219 | 0.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2014 | 2737 | 0.050 |
Why?
|
Lasers, Excimer | 1 | 2022 | 72 | 0.050 |
Why?
|
Heredodegenerative Disorders, Nervous System | 1 | 2001 | 17 | 0.050 |
Why?
|
Young Adult | 5 | 2021 | 56430 | 0.050 |
Why?
|
Physicians' Offices | 1 | 2021 | 58 | 0.050 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7181 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 2015 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2021 | 552 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2021 | 281 | 0.040 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2009 | 1344 | 0.040 |
Why?
|
Diplopia | 1 | 2020 | 200 | 0.040 |
Why?
|
Eye | 1 | 2023 | 729 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12720 | 0.040 |
Why?
|
Posture | 1 | 2022 | 958 | 0.040 |
Why?
|
Nervous System | 1 | 2001 | 554 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2001 | 2050 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 623 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3508 | 0.040 |
Why?
|
Blotting, Southern | 1 | 1998 | 803 | 0.040 |
Why?
|
Demyelinating Diseases | 1 | 2020 | 354 | 0.040 |
Why?
|
Lenses, Intraocular | 1 | 2019 | 140 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13284 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 2001 | 1950 | 0.040 |
Why?
|
Species Specificity | 1 | 2001 | 2478 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 2839 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2009 | 25625 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 63114 | 0.040 |
Why?
|
Canada | 1 | 2020 | 2065 | 0.030 |
Why?
|
Risk Assessment | 1 | 2016 | 23338 | 0.030 |
Why?
|
Home Care Services | 1 | 2021 | 606 | 0.030 |
Why?
|
Sexual Maturation | 1 | 2016 | 265 | 0.030 |
Why?
|
Risk Factors | 3 | 2016 | 72290 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2539 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1524 | 0.030 |
Why?
|
Uvea | 1 | 2013 | 31 | 0.030 |
Why?
|
Cohort Studies | 1 | 2016 | 40561 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3271 | 0.030 |
Why?
|
Subarachnoid Space | 1 | 2013 | 79 | 0.030 |
Why?
|
Occipital Lobe | 1 | 2014 | 379 | 0.030 |
Why?
|
Intracranial Pressure | 1 | 2014 | 326 | 0.030 |
Why?
|
Brain | 1 | 2019 | 26385 | 0.030 |
Why?
|
Exons | 1 | 1998 | 2437 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2014 | 981 | 0.030 |
Why?
|
Psychometrics | 1 | 2021 | 3002 | 0.030 |
Why?
|
Sclera | 1 | 2013 | 200 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12959 | 0.030 |
Why?
|
Sex Distribution | 1 | 2016 | 2297 | 0.020 |
Why?
|
Patient Compliance | 1 | 2021 | 2684 | 0.020 |
Why?
|
General Surgery | 1 | 2022 | 1636 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 950 | 0.020 |
Why?
|
Genetic Testing | 1 | 2023 | 3444 | 0.020 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1339 | 0.020 |
Why?
|
Age Distribution | 1 | 2016 | 2902 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2001 | 3617 | 0.020 |
Why?
|
Base Sequence | 1 | 2001 | 12797 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4740 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13815 | 0.020 |
Why?
|
Middle Aged | 2 | 2020 | 213383 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2021 | 3396 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 18111 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2001 | 11366 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1998 | 4328 | 0.020 |
Why?
|
Consensus | 1 | 2016 | 2959 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4149 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2005 | 15540 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 29144 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4687 | 0.020 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2022 | 21746 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9959 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7729 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9239 | 0.010 |
Why?
|
Animals | 2 | 2009 | 168757 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19905 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10397 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14722 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 15076 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29063 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12745 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40075 | 0.010 |
Why?
|